Goldring Mary B
Division of Rheumatology, Beth Israel Deaconess Medical Center, New England Baptist Bone and Joint Institute, Harvard Institutes of Medicine, Boston, MA, USA.
Methods Mol Med. 2004;100:23-36. doi: 10.1385/1-59259-810-2:023.
Immortalized chondrocytes of human origin have been developed to serve as reproducible models for studying chondrocyte function. In this chapter, methods for immortalization of primary human chondrocytes with SV40-TAg, HPV-16 E6/E7, and telomerase by retrovirally mediated transduction and selection for neomycin resistance are described. However, stable integration of an immortalizing gene stabilizes proliferative capacity, but not the differentiated chondrocyte phenotype. Thus, strategies for selection of chondrocyte cell lines, involving the maintenance of high cell density and moderation of cell proliferation, are also described. The methods for immortalization and selection are applicable to the development of chondrocyte cell lines using any immortalizing agent. Although immortalized chondrocytes should not be considered as substitutes for primary chondrocytes, they may be useful tools for evaluating and further validating mechanisms relevant to cartilage biology.
已开发出源自人类的永生化软骨细胞,用作研究软骨细胞功能的可重复模型。在本章中,描述了通过逆转录病毒介导的转导和新霉素抗性选择,用SV40-TAg、HPV-16 E6/E7和端粒酶对原代人软骨细胞进行永生化的方法。然而,永生化基因的稳定整合稳定了增殖能力,但未稳定分化的软骨细胞表型。因此,还描述了选择软骨细胞系的策略,包括维持高细胞密度和适度细胞增殖。永生化和选择方法适用于使用任何永生化剂开发软骨细胞系。尽管永生化软骨细胞不应被视为原代软骨细胞的替代品,但它们可能是评估和进一步验证与软骨生物学相关机制的有用工具。